
Invitae Corporation NVTA
Quarterly report 2023-Q3
added 05-23-2026
Invitae Corporation Total Inventories 2011-2026 | NVTA
Annual Total Inventories Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.4 M | 33.5 M | 32 M | 6.65 M | 8.3 M | 5.4 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.5 M | 5.4 M | 19.4 M |
Quarterly Total Inventories Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 M | 20.8 M | 19.1 M | 30.4 M | 29.9 M | 49.1 M | 43.5 M | 33.5 M | 30.6 M | 30 M | 30.7 M | 32 M | 14.9 M | 11.1 M | 13.3 M | 6.65 M | 6 M | 8.6 M | 8.8 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 5.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.1 M | 5.4 M | 20 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 204.05 | -0.23 % | $ 22.6 B | ||
|
Co-Diagnostics
CODX
|
992 K | $ 4.22 | -6.22 % | $ 5.61 M | ||
|
Castle Biosciences
CSTL
|
10.3 M | $ 21.34 | 1.23 % | $ 619 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
2.85 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
85.9 M | $ 130.56 | 0.33 % | $ 16.4 B | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 23.27 | 2.29 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 148.59 | -2.13 % | $ 11.7 B | ||
|
Illumina
ILMN
|
564 M | $ 163.32 | 2.06 % | $ 25.3 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 102.45 | 2.47 % | $ 6.91 B | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 188.83 | -0.54 % | $ 9.36 B | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
387 M | $ 1 131.19 | -2.73 % | $ 23.3 B | ||
|
NeoGenomics
NEO
|
28.6 M | $ 11.68 | 2.05 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.63 | 1.87 % | $ 429 M | ||
|
Natera
NTRA
|
68.4 M | $ 217.31 | -2.47 % | $ 29.7 B | ||
|
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.38 | 0.36 % | $ 414 M | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 7.22 | -2.83 % | $ 301 M | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
15 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.04 | -0.54 % | $ 4.69 M | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 67.91 | -3.07 % | $ 4.06 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 271.33 | 0.05 % | $ 22.6 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 484.82 | -1.87 % | $ 183 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.19 | -1.13 % | $ 1.99 B |